Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
The primary theoretical concern is that sustained NAD+ elevation through chronic NNMT inhibition could activate pathways (PARP, SIRT1) that have context-dependent roles in cancer biology NAD+ supports DNA repair and cellular longevity, but also fuels rapidly dividing cells
NNMT becomes a metabolic problem when it is overexpressed which is precisely what happens in obesity
However, it appears alongside peptides in the metabolic research space because its mechanism NNMT inhibition that preserves NAD+ and SAM pools intersects directly with the same cellular energy and epigenetic pathways that metabolic peptides target
The peptide has a molecular weight of 1815.12 g/mol, contains a stabilizing disulfide bridge, and is classified as a modified hGH fragment
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit
US$ 29.66
US$ 28.56
US$ 25.32
US$ 20.85
US$ 28.20
US$ 26.54